EDGAR Filing Documents for 0001600132-17-000047

Form 8-K - Current report:

SEC Accession No. 0001600132-17-000047

Filing Date

2017-05-12

Accepted

2017-05-11 19:42:20

Documents

Period of Report

2017-05-09

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a8-kmay2017offering.htm	8-K	37039
2	EXHIBIT 4.1	a8-kmay2017offeringex41.htm	EX-4.1	108987
3	EXHIBIT 5.1	a8-kmay2017offeringex51.htm	EX-5.1	16862
4	EXHIBIT 10.1	a8-kmay2017offeringex101.htm	EX-10.1	230981
5	EXHIBIT 10.2	a8-kmay2017offeringex102.htm	EX-10.2	49112
6	EXHIBIT 99.1	a8-kmay2017offeringex991.htm	EX-99.1	13221
7		hcw.jpg	GRAPHIC	3096
8		mintzlevin.jpg	GRAPHIC	117377
	Complete submission text file	0001600132-17-000047.txt		623511

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059

Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770

Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36845 | Film No.: 17835987
SIC: 2834 Pharmaceutical Preparations